1,850 results on '"Hemangioma therapy"'
Search Results
2. Comparison of the therapeutic effects of photodynamic therapy, transpupillary thermotherapy, and their combination on circumscribed choroidal haemangioma.
- Author
-
Si Y, Li Y, Zhao J, Bi X, Shi Q, Shi L, Wang Q, and Zhang P
- Subjects
- Humans, Female, Male, Middle Aged, Retrospective Studies, Adult, Combined Modality Therapy, Betamethasone therapeutic use, Aged, Verteporfin therapeutic use, Subretinal Fluid, Photochemotherapy methods, Choroid Neoplasms therapy, Choroid Neoplasms drug therapy, Hyperthermia, Induced methods, Hemangioma therapy, Hemangioma drug therapy, Photosensitizing Agents therapeutic use, Visual Acuity
- Abstract
Objective: To characterize the clinical and imaging features of circumscribed choroidal hemangioma (CCH), and to evaluate individualized treatment efficiency of photodynamic therapy (PDT), transpupillary thermotherapy (TTT), or their combination, followed by retrobulbar injection of betamethasone on CCH resolvement., Methods: Forty-nine patients with CCHs who underwent PDT, TTT or PDT+TTT treatments were retrospectively analyzed. Their treatment efficacy was compared by analyzing the change of best corrected visual acuity (BCVA), subretinal fluid (SRF) and CCH lesion characteristics., Results: PDT, TTT and PDT+TTT were respectively administrated in 17, 11 and 21 patients. No significant difference in age, gender, affected eyes and tumor location across the three groups. Baseline BCVA were 0.41 ± 0.28, 0.62 ± 0.30 and 0.24 ± 0.24 for PDT, TTT and PDT+TTT groups, respectively (F = 6.572, P = 0.003). CCH treated by three strategies showed significant difference in maximum tumor basal diameter, SRF areas and macula involvement prior to the treatment (P < 0.05). Patients receiving PDT+TTT exhibited larger tumor basal diameter, more SRF, higher ratio of macular involvement than other groups. A total of 38 (77.6 %) cases had good visual acidity with final BCVA ≥0.5 after treatments. PDT and PDT+TTT treatment groups acquired more vision improvement (0.27 ± 0.23 and 0.31 ± 0.26) in BCVA than TTT group (0.09 ± 0.13). All SRF were resolved within two weeks of treatment and no recurrent SRF were found., Conclusion: The three treatments showed good performance in improving visual function and controlling SRF, and individualized treatment should be selected primarily by the tumor location, and then the tumor size and presence of SRF., Competing Interests: Declaration of competing interest The authors declare no conflicts of interest., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. Management of circumscribed choroidal hemangioma at a tertiary care center.
- Author
-
Koç İ, Yücel Gençoğlu A, Yücekul B, Deliktaş Ö, Öztürk E, and Kiratli H
- Subjects
- Humans, Female, Male, Retrospective Studies, Middle Aged, Adult, Aged, Follow-Up Studies, Photochemotherapy methods, Hyperthermia, Induced methods, Fundus Oculi, Young Adult, Choroid pathology, Choroid blood supply, Choroid Neoplasms therapy, Choroid Neoplasms diagnosis, Tomography, Optical Coherence methods, Fluorescein Angiography methods, Tertiary Care Centers statistics & numerical data, Hemangioma therapy, Hemangioma diagnosis, Visual Acuity
- Abstract
Purpose: To review long-term outcomes of circumscribed choroidal hemangioma (CCH)., Methods: Hospital charts of all CCH cases diagnosed from 2008 to 2019 were retrospectively reviewed., Results: All 172 patients were managed with either observation, transpupillary thermotherapy, argon laser photocoagulation, photodynamic therapy, plaque brachytherapy or stereotactic radiosurgery. The most common 3 modes of management were clinical observation (30.2%), transpupillary thermotherapy (52.9%) and argon laser photocoagulation (8.7%). Median follow-up time was 10 months (range: 3, 160). Anatomical outcomes were stable in 87.1% of observation group and improved in 60.5% of thermotherapy group. Quantified optical coherence tomography angiography findings showed statistical differences in vascular and perfusion densities in fellow eyes of hemangioma patients., Conclusion: Circumscribed choroidal hemangioma can be treated in various ways. Transpupillary thermotherapy is an anatomically effective treatment in selected cases. The diagnosis of CCH may have vascular implications in fellow eyes of the patients., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)
- Published
- 2024
- Full Text
- View/download PDF
4. The Perfect Fit: Unraveling the Treatment Algorithms for Symptomatic Hepatic Hemangiomas.
- Author
-
Young S and Golzarian J
- Subjects
- Humans, Embolization, Therapeutic methods, Liver Neoplasms therapy, Liver Neoplasms diagnostic imaging, Hemangioma diagnostic imaging, Hemangioma therapy, Algorithms
- Published
- 2024
- Full Text
- View/download PDF
5. Interventional and device treatment of the periocular area.
- Author
-
Bajaj S, Orbuch D, Wang JV, Biesman BS, and Geronemus RG
- Subjects
- Humans, Rejuvenation, Tattooing, Cosmetic Techniques instrumentation, Skin Neoplasms therapy, Skin Neoplasms surgery, Lentigo therapy, Telangiectasis therapy, Hemangioma therapy, Laser Therapy
- Abstract
Growth in the research, innovation, and development of laser and energy-based technologies over the past few decades has led to dramatic increases in treatment options for dermatologic and cosmetic concerns of the periorbital area. We highlight recent treatment options using laser and energy-based devices for the clearance of periocular pigmented lesions, including solar lentigines and nevus of Ota; vascular lesions, including port-wine birthmarks, infantile hemangiomas, superficial telangiectasias, and reticular veins; laser ablation of benign tumors, such as xanthelasma; cosmetic rejuvenation; treatment of infraorbital dark circles and festoons; laser removal of eyebrow and eyeliner tattoos; and device-based treatment of chronic dry eyes., Competing Interests: Declaration of competing interest The authors declare no conflicts of interest., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
6. Evaluation and management of benign tumors of the eye and eyelid.
- Author
-
Brown R, Fard S, Feng P, and Kerr PE
- Subjects
- Humans, Eye Neoplasms therapy, Eye Neoplasms diagnosis, Dermoid Cyst therapy, Neurofibroma therapy, Neurofibroma surgery, Hemangioma therapy, Epidermal Cyst therapy, Epidermal Cyst diagnosis, Epidermal Cyst surgery, Nevus, Pigmented therapy, Keratosis, Seborrheic therapy, Keratosis, Seborrheic diagnosis, Neurilemmoma therapy, Laser Therapy, Xanthomatosis therapy, Eyelid Neoplasms therapy
- Abstract
Benign tumors of the eye and eyelid are common in children and adults, and they rarely undergo malignant transformation. Their workup and management have evolved over the years with increasing advancements in surgical and laser therapies. This contribution focuses on describing the following benign eye and eyelid tumors and their diagnostic and treatment approaches: congenital and acquired melanocytic nevi; nevus of Ota (Hori nevus); conjunctival papilloma; seborrheic keratosis; epidermoid cyst; dermoid cyst; milium; xanthelasma; hemangioma (cherry angioma and pyogenic granuloma); neurofibroma; neurilemmoma (schwannoma); and fibroepithelial polyp. Surgical removal is the primary treatment approach for many of these benign tumors. With advancements in laser technologies, there are now several laser types that can be used in the treatment of these benign eye and eyelid tumors. Other treatment modalities include cryosurgery, electrosurgery, and topical or intralesional medications. We hope this review will provide a reference to dermatologists and ophthalmologists in their approach to evaluation and management of benign eye and eyelid tumors., Competing Interests: Declaration of competing interest The authors declare no conflicts of interest., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
7. ACG Clinical Guideline: Focal Liver Lesions.
- Author
-
Frenette C, Mendiratta-Lala M, Salgia R, Wong RJ, Sauer BG, and Pillai A
- Subjects
- Humans, Diagnosis, Differential, Gastroenterology standards, Carcinoma, Hepatocellular diagnosis, Carcinoma, Hepatocellular pathology, Carcinoma, Hepatocellular therapy, Carcinoma, Hepatocellular diagnostic imaging, Focal Nodular Hyperplasia diagnosis, Focal Nodular Hyperplasia pathology, Liver Neoplasms diagnosis, Liver Neoplasms pathology, Liver Neoplasms therapy, Liver Neoplasms diagnostic imaging, Liver Diseases diagnosis, Liver Diseases therapy, Liver Diseases diagnostic imaging, Liver Diseases pathology, Hemangioma diagnosis, Hemangioma therapy, Hemangioma pathology, Hemangioma diagnostic imaging, Cysts diagnosis, Cysts diagnostic imaging, Cysts pathology, Adenoma, Liver Cell diagnosis, Adenoma, Liver Cell pathology, Adenoma, Liver Cell therapy, Adenoma, Liver Cell diagnostic imaging
- Abstract
Focal liver lesions (FLLs) have become an increasingly common finding on abdominal imaging, especially asymptomatic and incidental liver lesions. Gastroenterologists and hepatologists often see these patients in consultation and make recommendations for management of multiple types of liver lesions, including hepatocellular adenoma, focal nodular hyperplasia, hemangioma, and hepatic cystic lesions including polycystic liver disease. Malignancy is important to consider in the differential diagnosis of FLLs, and healthcare providers must be familiar with the diagnosis and management of FLLs. This American College of Gastroenterology practice guideline uses the best evidence available to make diagnosis and management recommendations for the most common FLLs., (Copyright © 2024 by The American College of Gastroenterology.)
- Published
- 2024
- Full Text
- View/download PDF
8. Transcatheter Arterial Embolization with Bleomycin-Lipiodol of Hepatic Hemangiomas: Safety, Efficacy and Predictors of Response.
- Author
-
Zhao D, Xie L, Makamure J, Liu Z, Zhang L, Li Q, Zhang X, Zhao Y, Zheng C, Shi L, and Liang B
- Subjects
- Humans, Male, Retrospective Studies, Female, Middle Aged, Adult, Treatment Outcome, Aged, Embolization, Therapeutic methods, Antibiotics, Antineoplastic therapeutic use, Antibiotics, Antineoplastic administration & dosage, Tumor Burden, Chemoembolization, Therapeutic methods, Gelatin Sponge, Absorbable therapeutic use, Ethiodized Oil administration & dosage, Ethiodized Oil therapeutic use, Liver Neoplasms therapy, Liver Neoplasms diagnostic imaging, Bleomycin therapeutic use, Hemangioma therapy, Hemangioma diagnostic imaging
- Abstract
Purpose: To evaluate the safety, efficacy and predictors of response of transcatheter arterial embolization (TAE) to treat hepatic hemangiomas (HHs)., Materials and Methods: A retrospective analysis was conducted of consecutive HH patients who received TAE with bleomycin-Lipiodol emulsion and gelatin sponge particles at three institutions from January 2014 to January 2021. TAE effectiveness was defined as more than 50% reduction of tumor volume. The effectiveness, safety, and CT changes of hemangiomas after TAE were assessed. Factors affecting TAE efficacy on tumor size were analyzed with logistic regression analysis., Results: A total of 102 patients with 109 HHs were included. After treatment, both the tumor diameter and volume were significantly reduced from 8.5 ± 3.9 to 5.9 ± 3.8 cm (P < 0.001) and 412.6 ± 742.3 cm
3 to 102.0 ± 232.7 cm3 (P < 0.001), respectively. TAE effectiveness was achieved in 80.7% (88/109) of hemangiomas, which was characterized by progressive reduction in tumor volume over time with Lipiodol retention. Atypical enhancement pattern (tiny enhancing dots in the hepatic arterial and portal venous phase) (p = 0.001) and central arterioportal shunt (APS) (p = 0.002) associated with the tumor were independent predictors of TAE ineffectiveness. Postembolization syndrome and transient increase in liver enzymes were common without severe complications and death., Conclusion: TAE was safe and effective in reducing HH size. Lesion enhancement pattern and APS type were associated with TAE efficacy on tumor shrinkage., Level of Evidence: Level 3, non-controlled retrospective cohort study., (© 2024. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).)- Published
- 2024
- Full Text
- View/download PDF
9. Swept-source optical coherence tomography and swept-source optical coherence tomography angiography findings in circumscribed choroidal hemangioma before and after transpupillary thermotherapy.
- Author
-
Mirzayev I, Gündüz AK, and Ergin A
- Subjects
- Humans, Female, Middle Aged, Male, Adult, Aged, Fluorescein Angiography methods, Retrospective Studies, Choroid diagnostic imaging, Choroid blood supply, Choroid pathology, Tomography, Optical Coherence methods, Choroid Neoplasms therapy, Choroid Neoplasms diagnostic imaging, Choroid Neoplasms pathology, Hemangioma therapy, Hemangioma diagnostic imaging, Hemangioma pathology, Hyperthermia, Induced methods
- Abstract
Purpose: To investigate the swept-source optical coherence tomography (SS-OCT) and SS-OCT angiography (SS-OCTA) findings in circumscribed choroidal hemangioma (CCH) before and after treatment with transpupillary thermotherapy (TTT)., Methods: The clinical records of 21 eyes having CCH imaged with SS-OCT/SS-OCTA between September 2018 and December 2022 were evaluated., Results: SS-OCT examination in CCH showed dome-shaped appearance (100%), choroidal shadowing (100%), expansion of choroidal structures (100%), subretinal fluid (66.7%), intraretinal edema/schisis (33.3%), retinal pigment epithelium (RPE) atrophy (19.0%), hyperreflective dots (19.0%), and epiretinal membrane (4.8%). Internal arborizing tumor vessels showing hyperreflectivity were observed in the choriocapillaris slab on SS-OCTA in all eyes. In the deep capillary plexus (DCP), flow void changes were seen in 7 eyes with intraretinal schisis/cystoid macular edema. Four CCHs > 2 mm in thickness showed outer retinal involvement due to unmasking of flow in intratumoral vessels related to RPE atrophy. Following TTT/indocyanine green-enhanced TTT (ICG-TTT) of CCH, SS-OCT findings included total/partial resolution of subretinal fluid (57.1%), complete/partial regression of the tumor (52.4%), and RPE atrophy (33.3%). After treatment; loss of choriocapillaris, decrease in tumor vascularity together with increase in the fibrous component and flow void areas were detected on SS-OCTA., Conclusions: SS-OCT/SS-OCTA are useful non-invasive tools for imaging the structural/vascular changes in CCHs managed with TTT or ICG-TTT. On SS-OCTA, hyporeflective spaces localizing to edema/schisis in the DCP and arborizing tumor vessels within a hyporeflective stromal background in the choriocapillaris slab were observed. After TTT/ICG-TTT, a decrease in tumor vessels and an increase in the fibrous component and flow-void areas inside the CCH were detected on SS-OCTA., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
10. Transarterial embolization with bleomycin-lipiodol emulsion: a successful minimal invasive approach for giant liver hemangioma.
- Author
-
Kurniawan J, Teressa M, Budiman RA, and Matondang SBRE
- Subjects
- Humans, Antibiotics, Antineoplastic administration & dosage, Antibiotics, Antineoplastic therapeutic use, Female, Male, Middle Aged, Emulsions, Chemoembolization, Therapeutic methods, Liver Neoplasms therapy, Liver Neoplasms diagnostic imaging, Hemangioma therapy, Hemangioma diagnostic imaging, Ethiodized Oil administration & dosage, Bleomycin administration & dosage, Bleomycin therapeutic use, Embolization, Therapeutic methods
- Abstract
Hemangiomas are most common benign liver tumor. Most patients have an excellent prognosis because of the small size and benign nature of tumor. On some occasions, giant liver hemangioma may cause symptoms and significant challenges due to its complication. We report a case of giant liver hemangioma treated with minimal invasive approach by transarterial embolization (TAE). Following three TAE sessions over a specific timeframe, the patient was successfully managed, addressing that TAE may be a useful alternative to hepatic surgery in such cases., (© 2024. Japanese Society of Gastroenterology.)
- Published
- 2024
- Full Text
- View/download PDF
11. Ultrasound and X-ray guided prenatal embolization of massive chorioangioma.
- Author
-
Morvan A, Soussan J, Chaumoître K, D'Ercole C, and Castel P
- Subjects
- Humans, Female, Pregnancy, Adult, Hemangioma diagnostic imaging, Hemangioma therapy, Embolization, Therapeutic methods, Ultrasonography, Prenatal
- Abstract
Competing Interests: Declaration of competing interest All authors declare that they have no conflicts of interest.
- Published
- 2024
- Full Text
- View/download PDF
12. Efficacy of radiofrequency ablation vs. transcatheter arterial embolization for hepatic hemangiomas.
- Author
-
Li J, Zhang S, Ning C, Li G, and Guo S
- Subjects
- Humans, Male, Female, Middle Aged, Retrospective Studies, Treatment Outcome, Adult, Radiofrequency Ablation adverse effects, Radiofrequency Ablation methods, Length of Stay, Aged, Postoperative Complications etiology, Catheter Ablation methods, Catheter Ablation adverse effects, Time Factors, Tumor Burden, Liver Neoplasms therapy, Hemangioma therapy, Chemoembolization, Therapeutic methods, Chemoembolization, Therapeutic adverse effects, Operative Time
- Abstract
Objective: The objective of this study was to evaluate the safety and effectiveness of radiofrequency ablation (RFA) and transcatheter arterial chemoembolization (TACE) in the treatment of large hepatic hemangiomas (LHH) (5-9.9 cm in diameter)., Methods and Materials: This study retrospectively collected data from 82 patients with LHH treated at Chaoyang Central Hospital. The study analyzed the differences in postoperative efficacy, operative time, blood routine, liver and kidney function on the first day after surgery, postoperative hospitalization time and postoperative complications., Results: There were statistically significant differences in indicators such as white blood cell count, alanine aminotransferase, aspartate aminotransferase and total bilirubin on the first day after surgery between the RFA group (39 cases) and the TACE group (43 cases) ( P < 0.001). Compared to RFA, LHH patients treated with TACE had a general complication rate of 39.5% (vs. 43.6%; P = 0.7), a procedure-related complication rate of 30.2% (vs. 59.0%; P = 0.009), an effective rate at 6-12 months postoperatively of 55.8% (vs. 82.1%; P = 0.01), an operating-time of 41.2 ± 14.9 min (vs. 100.8 ± 35.5 min; P < 0.001) and hospitalization costs of 17052.7 ± 1364.8 yuan (vs. 30952.1 ± 4327.6 yuan; P < 0.001)., Conclusion: This study indicates that the efficacy of RFA in treating LHH is significantly superior to TACE. Microwave ablation and RFA appear to be safe treatments for LHH. The TACE group exhibited shorter operating-time, lower hospitalization costs and lower demands on cardiopulmonary function., (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
13. Vertebral hemangiomas: a review on diagnosis and management.
- Author
-
Kato K, Teferi N, Challa M, Eschbacher K, and Yamaguchi S
- Subjects
- Humans, Retrospective Studies, Tomography, X-Ray Computed, Male, Female, Middle Aged, Hemangioma therapy, Hemangioma diagnostic imaging, Hemangioma diagnosis, Spinal Neoplasms therapy, Spinal Neoplasms diagnostic imaging, Magnetic Resonance Imaging
- Abstract
Background: Vertebral hemangiomas (VHs) are the most common benign tumors of the spinal column and are often encountered incidentally during routine spinal imaging., Methods: A retrospective review of the inpatient and outpatient hospital records at our institution was performed for the diagnosis of VHs from January 2005 to September 2023. Search filters included "vertebral hemangioma," "back pain," "weakness," "radiculopathy," and "focal neurological deficits." Radiographic evaluation of these patients included plain X-rays, CT, and MRI. Following confirmation of a diagnosis of VH, these images were used to generate the figures used in this manuscript. Moreover, an extensive literature search was conducted using PubMed for the literature review portion of the manuscript., Result: VHs are benign vascular proliferations that cause remodeling of bony trabeculae in the vertebral body of the spinal column. Horizontal trabeculae deteriorate leading to thickening of vertical trabeculae which causes a striated appearance on sagittal magnetic resonance imaging (MRI) and computed tomography (CT), "Corduroy sign," and a punctuated appearance on axial imaging, "Polka dot sign." These findings are seen in "typical vertebral hemangiomas" due to a low vascular-to-fat ratio of the lesion. Contrarily, atypical vertebral hemangiomas may or may not demonstrate the "Corduroy" or "Polka-dot" signs due to lower amounts of fat and a higher vascular component. Atypical vertebral hemangiomas often mimic other neoplastic pathologies, making diagnosis challenging. Although most VHs are asymptomatic, aggressive vertebral hemangiomas can present with neurologic sequelae such as myelopathy and radiculopathy due to nerve root and/or spinal cord compression. Asymptomatic vertebral hemangiomas do not require therapy, and there are many treatment options for vertebral hemangiomas causing pain, radiculopathy, and/or myelopathy. Surgery (corpectomy, laminectomy), percutaneous techniques (vertebroplasty, sclerotherapy, embolization), and radiotherapy can be used in combination or isolation as appropriate. Specific treatment options depend on the lesion's size/location and the extent of neural element compression. There is no consensus on the optimal treatment plan for symptomatic vertebral hemangioma patients, although management algorithms have been proposed., Conclusion: While typical vertebral hemangioma diagnosis is relatively straightforward, the differential diagnosis is broad for atypical and aggressive lesions. There is an ongoing debate as to the best approach for managing symptomatic cases, however, surgical resection is often considered first line treatment for patients with neurologic deficit., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
14. Interdisciplinary Management of Vascular Anomalies in the Head and Neck.
- Author
-
Mattheis S and Wanke I
- Subjects
- Humans, Combined Modality Therapy, Embolization, Therapeutic, Head blood supply, Head and Neck Neoplasms therapy, Head and Neck Neoplasms diagnosis, Hemangioma therapy, Hemangioma diagnosis, Interdisciplinary Communication, Intersectoral Collaboration, Patient Care Team, Sclerotherapy, Neck blood supply, Vascular Malformations therapy, Vascular Malformations diagnosis
- Abstract
Vascular anomalies in the head and neck area are usually rare diseases and pose a particular diagnostic and therapeutic challenge. They are divided into vascular tumours and vascular malformations. A distinction is made between benign tumours, such as infantile haemangioma, and rare malignant tumours, such as angiosarcoma. Vascular malformations are categorised as simple malformations, mixed malformations, large vessel anomalies and those associated with other anomalies. Treatment is interdisciplinary and various modalities are available. These include clinical observation, sclerotherapy, embolisation, ablative and coagulating procedures, surgical resection and systemic drug therapy. Treatment is challenging, as vascular anomalies in the head and neck region practically always affect function and aesthetics. A better understanding of the genetic and molecular biological basis of vascular anomalies has recently led to clinical research into targeted drug therapies. This article provides an up-to-date overview of the diagnosis, clinic and treatment of vascular anomalies in the head and neck region., Competing Interests: S.M. gibt folgendes an: Firma Medtronic GmbH, Meerbusch - Dozenten und Beratertätigkeit; Firma Olympus, Hamburg - Dozenten und Beratertätigkeit I.W. gibt an, dass kein Interessenkonflikt besteht., (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).)
- Published
- 2024
- Full Text
- View/download PDF
15. Recent updates in laryngeal hemangioma management: a scoping review.
- Author
-
Almothahbi A, Bukhari M, Almohizea M, Alsubaie N, Alharbi TF, Alhazzani HM, and Zagzoog F
- Subjects
- Humans, Adrenergic beta-Antagonists therapeutic use, Propranolol therapeutic use, Tracheostomy, Treatment Outcome, Hemangioma therapy, Hemangioma drug therapy, Laryngeal Neoplasms therapy, Laryngeal Neoplasms drug therapy
- Abstract
Purpose: To provide a comprehensive review of the current strategies in the management of laryngeal hemangiomas, with an aim to introduce a management algorithm that aligns with the variable clinical presentations and anatomical complexities of these lesions., Methods: We conducted an extensive literature search across major databases using specific and general terms, combined with Boolean operators, to ensure comprehensiveness. Articles from January 2004 to August 2023 were included, with findings categorized by management approach., Results: Laryngeal hemangiomas exhibit a spectrum of manifestations, ranging from asymptomatic lesions to those causing severe airway obstruction. Optimal management demands an individualized approach tailored to the patient's unique presentation and anatomical considerations. Diverse treatment modalities, each with distinct indications, advantages, and limitations, are explored. Notable highlights encompass the prominent role of Beta-blockers, notably Propranolol, in addressing problematic infantile hemangiomas, the nuanced efficacy of laser therapies contingent upon hemangioma type and depth, and the critical relevance of tracheotomy in emergencies. Novel approaches like transoral robotic surgery and transoral ultrasonic surgery, demonstrate promise in specific scenarios. We propose a management algorithm based on the complexity and presentation of laryngeal hemangiomas, emphasizing individualized treatment strategies, thereby addressing the unique challenges and nuances of each case., Conclusion: Laryngeal hemangioma management requires personalized approaches informed by diverse therapies, clinical expertise, and collaboration. The review introduces an algorithm spanning observation to advanced interventions, adapting to each case's complexity. Ongoing research promises innovative treatments., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
16. Successful interventional treatment of huge hepatic haemangioma in a neonate following failed medical approach.
- Author
-
Roy A, Yadav RR, Naranje K, and Singh A
- Subjects
- Infant, Newborn, Infant, Humans, Male, Propranolol therapeutic use, Hepatic Artery, Ultrasonography, Hemangioma diagnostic imaging, Hemangioma therapy, Liver Neoplasms diagnostic imaging, Liver Neoplasms therapy
- Abstract
An outborn male term neonate presented with a complaint of respiratory distress since birth on day 9 of life. On examination, baby was having tachypnoea, tachycardia and hepatomegaly. The baby was delivered at term gestation and cried immediately after birth. The chest X-ray showed cardiomegaly. The abdomen ultrasound showed a complex cystic vascular lesion suggestive of hepatic haemangioma. The echocardiography showed an atrial septal defect. The baby was initially treated conservatively along with specific treatment (steroids and propranolol) for haemangioma for 6 weeks. However, the symptoms persisted and there was non-resolution, therefore, particle embolisation of the right hepatic artery was performed. Subsequently, it resulted in complete resolution of the lesion., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
17. New insights on circumscribed choroidal hemangioma: "bench to bedside".
- Author
-
Lupidi M, Centini C, Castellucci G, Nicolai M, Lassandro N, Cagini C, Rizzo C, Chhablani J, and Mariotti C
- Subjects
- Humans, Choroid pathology, Fluorescein Angiography, Tomography, Optical Coherence, Hemangioma diagnosis, Hemangioma therapy, Hemangioma pathology, Choroid Neoplasms diagnosis, Choroid Neoplasms therapy, Photochemotherapy
- Abstract
Circumscribed choroidal hemangioma is a rare vascular hamartoma of the choroid, presenting as a red-orange mass at the posterior pole on fundoscopic examination. Despite its benign origin, associated complications such as subretinal fluid, serous retinal detachment, retinoschisis and neovascular glaucoma may lead to serious visual impairment in more than half patients. Because of its similarity to amelanotic choroidal melanoma and choroidal metastasis, differential diagnosis is still challenging for specialists. Multimodal imaging such as ultrasonography, fluorescein angiography, indocyanine green angiography, optical coherence tomography, and optical coherence tomography angiography guides the clinician to the correct diagnosis and the proper follow-up. Treatment is indicated in symptomatic cases in order to resolve exudation and improve visual acuity. Treatment options include photocoagulation, transpupillary thermotherapy, radiation therapy, photodynamic therapy and anti-vascular endothelial growth factor therapy. Currently, photodynamic therapy is the treatment of choice due to its effectiveness and safety. The purpose of this review is to describe the latest knowledge in the etiopathogenesis of the circumscribed choroidal hemangioma, the most recent multimodal imaging findings, and the available treatment options., (© 2023. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
18. Infantile Hemangiomas and Vascular Anomalies.
- Author
-
Paradiso MM, Shah SD, and Fernandez Faith E
- Subjects
- Humans, Vascular Neoplasms diagnosis, Vascular Neoplasms therapy, Vascular Malformations diagnosis, Vascular Malformations therapy, Vascular Malformations pathology, Hemangioma diagnosis, Hemangioma therapy, Hemangioma pathology, Kasabach-Merritt Syndrome, Hemangioendothelioma
- Abstract
Vascular anomalies represent a diverse group of disorders of abnormal vascular development or proliferation. Vascular anomalies are classified as vascular tumors and vascular malformations. Significant advances have been made in the understanding of the pathogenesis, natural history, and genetics of vascular anomalies, allowing for improvements in management including targeted molecular therapies. Infantile hemangiomas are the most common vascular tumor of childhood and follow a distinct natural history of proliferation and involution. Although benign, infantile hemangiomas can be associated with important complications. The use of beta-blockers has revolutionized the management of infantile hemangiomas. Other vascular tumors include pyogenic granulomas, congenital hemangiomas, and kaposiform hemangioendotheliomas, among others. Vascular malformations are categorized based on the type of involved vessel, including capillary malformations, venous malformations, lymphatic malformations, arteriovenous malformations, and mixed vascular malformations. Expert multidisciplinary management of vascular anomalies is critical to optimize outcomes in these patients. [ Pediatr Ann . 2024;53(4):e129-e137.] .
- Published
- 2024
- Full Text
- View/download PDF
19. Hepatic Hemangioma: Review of Imaging and Therapeutic Strategies.
- Author
-
Kacała A, Dorochowicz M, Matus I, Puła M, Korbecki A, Sobański M, Jacków-Nowicka J, Patrzałek D, Janczak D, and Guziński M
- Subjects
- Humans, Magnetic Resonance Imaging methods, Liver Neoplasms diagnostic imaging, Liver Neoplasms therapy, Liver Neoplasms pathology, Carcinoma, Hepatocellular therapy, Chemoembolization, Therapeutic, Hemangioma diagnostic imaging, Hemangioma therapy, Hemangioma, Cavernous diagnostic imaging, Hemangioma, Cavernous therapy
- Abstract
Hepatic hemangiomas are the most common benign liver tumors. Typically, small- to medium-sized hemangiomas are asymptomatic and discovered incidentally through the widespread use of imaging techniques. Giant hemangiomas (>5 cm) have a higher risk of complications. A variety of imaging methods are used for diagnosis. Cavernous hemangioma is the most frequent type, but radiologists must be aware of other varieties. Conservative management is often adequate, but some cases necessitate targeted interventions. Although surgery was traditionally the main treatment, the evolution of minimally invasive procedures now often recommends transarterial chemoembolization as the treatment of choice.
- Published
- 2024
- Full Text
- View/download PDF
20. Medical Management of Nonmalignant Vascular Tumors of the Head and Neck: Part 1.
- Author
-
Gatts J, Chandra S, Krishnan D, and Ricci K
- Subjects
- Humans, Endothelial Cells pathology, Neck, Hemangioma therapy, Hemangioma diagnosis, Hemangioma pathology, Vascular Malformations therapy, Vascular Malformations pathology, Head and Neck Neoplasms therapy
- Abstract
Vascular anomalies, broadly classified as nonmalignant tumors and malformations, consist of a multitude of disorders that have a wide range of symptoms and complications as well as overlapping clinical, radiologic, and histologic findings. Although usually difficult, distinguishing between nonmalignant vascular tumors and malformations, as well as the precise diagnosis within these distinctions, is critical because prognosis, therapy, and chronicity of care vary greatly. In contrast to normal endothelial turnover in vascular malformations, vascular tumors are characterized by the abnormal proliferation of endothelial cells and aberrant blood vessels., Competing Interests: Disclosure The authors have no conflicts of interest to disclose., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
21. Postnatal treatment and evolution patterns of giant fetal hepatic hemangioma: a case series of 29 patients.
- Author
-
Xie LL, Huang YB, Dong KR, Yang SB, Shen C, and Ma YY
- Subjects
- Pregnancy, Infant, Newborn, Child, Female, Humans, Infant, Propranolol therapeutic use, Retrospective Studies, Hemangioma diagnostic imaging, Hemangioma therapy, Liver Neoplasms diagnostic imaging, Liver Neoplasms therapy, Liver Neoplasms pathology, Infant, Newborn, Diseases
- Abstract
Objectives: To explore the clinical characteristics, postnatal treatment and prognosis of giant fetal hepatic hemangioma (GFHH)., Method: Retrospective analysis was performed on children with giant fetal hepatic hemangioma (maximum tumor diameter > 40 mm) diagnosed by prenatal ultrasound and MRI from December 2016 to December 2020. These patients were observed and treated at the Children's Hospital of Fudan University after birth. The clinical data were collected to analyze the clinical characteristics, treatment, and prognosis of GFHH using independent sample t tests or Fisher's exact tests., Results: Twenty-nine patients who were detected by routine ultrasound in the second and third trimester of pregnancy with giant fetal hepatic hemangiomas were included. The first prenatal ultrasound diagnosis of gestational age was 34.0 ± 4.3 weeks, ranging from 22 to 39 weeks. Of the patients, 28 had focal GFHHs and 1 had multifocal GFHHs. Surgery was performed, and the diagnosis was confirmed histopathologically in two patients. There were 8 cases with echocardiography-based evidence of pulmonary hypertension, 11 cases had a cardiothoracic ratio > 0.6, and 4 cases had hepatic arteriovenous fistula (AVF). The median follow-up time was 37 months (range: 14-70 months). During the follow-up, 12 patients received medical treatment with propranolol as the first-line therapy. The treatment group had a higher ratio of cardiothoracic ratio > 0.6 (P = 0.022) and lower albumin levels (P = 0.018). Four (14.8%) lesions showed postnatal growth before involuting. Complete response was observed in 13 (13/29) patients, and partial response was observed in 16 (16/29) patients., Conclusions: Fetal giant hepatic hemangioma is mainly localized, and its clinical outcome conforms to RICH (rapidly involuting) and PICH (partially involuting), but some fetal giant hepatic hemangiomas will continue to grow after birth and then gradually decrease. For uncomplicated giant fetal hepatic hemangioma, postnatal follow-up is the main concern, while those with complications require aggressive medical treatment. Propranolol may have no effect on the volume change of GFHH., (© 2023. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
22. [Sinonasal hemangiomas: principles of diagnosis and treatment. Literature review].
- Author
-
Tovmasyan AS, Klimenko KE, Zelikovich EI, Kurilenkova AG, Filina EV, Kishinevskii AE, and Ramazanov SR
- Subjects
- Humans, Endoscopy methods, Nose Neoplasms diagnosis, Nose Neoplasms therapy, Nose Neoplasms surgery, Nasal Cavity surgery, Nasal Cavity pathology, Nasal Cavity diagnostic imaging, Tomography, X-Ray Computed methods, Magnetic Resonance Imaging methods, Paranasal Sinus Neoplasms diagnosis, Paranasal Sinus Neoplasms surgery, Paranasal Sinus Neoplasms therapy, Hemangioma diagnosis, Hemangioma therapy, Hemangioma surgery
- Abstract
Hemangiomas of the nasal cavity are extremely rare in the practice of an otorhinolaryngologist and can be presented in various histopathological variants. Scientific data on hemangiomas of the sinonasal region are analyzed and systematized. The article describes the principles of diagnosis and choice of the method of surgical treatment of hemangiomas. An analysis of the literature data shows that with hemangiomas of the nasal cavity, a comprehensive examination of the patient is required, including collection of complaints and anamnesis, endoscopy of the nasal cavity and computed tomography of the paranasal sinuses, and with significant hemangiomas spreading to neighboring anatomical areas, magnetic resonance imaging with intravenous contrast.
- Published
- 2024
- Full Text
- View/download PDF
23. Guía mexicana para el diagnóstico y el tratamiento del hemangioma infantil.
- Author
-
Toledo-Bahena ME, Camargo-Sánchez KA, Cruz HV, Valencia-Herrera AM, Ocáriz MMS, Duarte-Abdala MR, Osuna-Osuna J, Aranda-Mendoza J, Rosales-Solís GM, Maza-Ramos G, Orozco-Covarrubias ML, Valle PL, Erdmenger-Orellana JR, Enríquez-García R, Dies-Suárez P, Celis-Jiménez A, and Mena-Cedillos CA
- Subjects
- Humans, Infant, Follow-Up Studies, Mexico, Quality of Life, Hemangioma diagnosis, Hemangioma therapy
- Abstract
Infantile hemangioma is a benign vascular tumor, the most common in childhood, whose natural evolution is the disappearance of the lesion in the pediatric age and which has effective and safe treatments that limit its growth and favor its disappearance at younger ages. Infantile hemangioma continues to be a reason for attention to complications, due to erroneous diagnoses, lack of knowledge of the condition, late referral or fear of the effects of the medications used for its treatment. Furthermore, its presence is normalized without taking into account that it can cause uncertainty, anxiety, feelings of guilt and, as a consequence, a significant impact on the quality of life, mainly in the parents or caregivers of the child. The need for a clinical practice guideline in our country arises from the high presentation of late-remitted complications in infantile hemangioma even with the availability of adequate treatments, the continuous evolution of medicine and the appearance of new evidence. Throughout the guide you will find recommendations regarding the diagnosis, treatment and follow-up of patients with infantile hemangioma, taking into account the paraclinical tests that can be performed, topical or systemic management options, as well as adjuvant therapies. For the first time, objective tools for patient follow-up are included in a guide for the management of infantile hemangioma, as well as to help the first contact doctor in timely referral., (Copyright: © 2024 Permanyer.)
- Published
- 2024
- Full Text
- View/download PDF
24. Endoscopic Ultrasound-Guided Sclerotherapy With Lauromacrogol: A Novel Therapy for A Giant Esophageal Hemangioma.
- Author
-
Feng X and Li H
- Subjects
- Humans, Polidocanol, Sclerotherapy, Polyethylene Glycols, Ultrasonography, Interventional, Hemangioma diagnostic imaging, Hemangioma therapy, Hemangioma, Cavernous, Esophageal and Gastric Varices diagnostic imaging, Esophageal and Gastric Varices therapy
- Published
- 2024
- Full Text
- View/download PDF
25. Percutaneous microwave ablation versus sclerotherapy for large hepatic hemangioma: a multi-center cohort study.
- Author
-
Cai Q, Qian TG, Zhao QY, Feng SY, Yang Q, Luo YC, Dai YQ, Liang P, Yu XL, Liu FY, Han ZY, Du QW, Li X, and Yu J
- Subjects
- Humans, Sclerotherapy, Microwaves therapeutic use, Retrospective Studies, Hemangioma diagnostic imaging, Hemangioma therapy, Liver Neoplasms therapy
- Abstract
Objective: The study aimed to compare the effectiveness and safety of ultrasound-guided microwave ablation (MWA) and percutaneous sclerotherapy (PS) for the treatment of large hepatic hemangioma (LHH)., Methods: This retrospective study included 96 patients who underwent MWA ( n = 54) and PS ( n = 42) as first-line treatment for LHH in three tertiary hospitals from January 2016 to December 2021. Primary outcomes were technique efficacy rate (volume reduction rate [VRR] > 50% at 12 months), symptom relief rate at 12 months and local tumor progression (LTP). Secondary outcomes included procedure time, major complications, treatment sessions, cost and one-, two-, three-year VRR., Results: During a median follow-up of 36 months, the MWA group showed a higher technique efficacy rate (100% vs. 90.4%, p = .018) and symptom relief rate (100% vs. 80%, p = .123) than the PS group. The MWA group had fewer treatment sessions, higher one-, two- and three-year VRR, lower LTP rate (all p < .05), longer procedure time and higher treatment costs than the PS group (both p < .001). MWA shared a comparable major complications rate (1.8% vs. 2.4%, p = .432) with PS. After multivariate analysis, the lesion's heterogeneity and maximum diameter >8.1 cm were independent risk factors for LTP (all p < .05). In the PS group, lesions with a cumulative dose of bleomycin > 0.115 mg/cm
3 had a lower risk of LTP ( p = .006)., Conclusions: Both MWA and PS treatments for large hepatic hemangioma are safe and effective, with MWA being superior in terms of efficacy.- Published
- 2024
- Full Text
- View/download PDF
26. Hemangioma of the Urinary Bladder: A Brief Narrative Review of Their Diagnosis, Histology, and Treatment Options.
- Author
-
Garaz R, Stühler V, Stenzl A, Rottscholl R, and Amend B
- Subjects
- Humans, Urinary Bladder pathology, Hematuria etiology, Hematuria pathology, Cystoscopy, Hemangioma diagnosis, Hemangioma therapy, Hemangioma pathology, Urinary Bladder Neoplasms diagnosis, Urinary Bladder Neoplasms therapy, Urinary Bladder Neoplasms pathology
- Abstract
Background: Hemangioma of the urinary bladder is a rare benign tumor. Although benign, their presenting symptoms are alarming for both patients and doctors, and their rarity makes them challenging to correctly diagnosis and treat. This review paper summarizes current knowledge about hemangioma of the urinary bladder, treatment options, and follow-up modalities., Summary: After the kidney, the bladder is the second most common location of hemangiomas in the urinary tract. There is painless gross hematuria on clinical presentation once the lesion has eroded the urothelium. Magnetic resonance imaging (MRI) has been reported to be valuable in diagnosing soft-tissue hemangiomas. Cystoscopic findings of a sessile, blue, multilocular mass suggest hemangioma. Most tumors are solitary, smaller than 3 cm, and have smooth or irregular surfaces. Histologically, lesions comprise numerous proliferative capillaries with thin-walled, dilated, blood-filled vessels lined with flattened endothelium. The treatment of patients with hemangioma has been controversial. It depends on the tumor size and the degree of penetration. The prognosis of these tumors is excellent., Key Messages: Despite the widespread use of MRI, CT, and endoscopy in evaluating hematuria, hemangioma remains one of the rarest bladder tumors. Moreover, only a histological examination can confirm the diagnosis. Transurethral resection, fulguration, and YAG laser ablation are standard treatments for small tumors. In terms of follow-up, cystoscopy after 6 months of treatment helps assess recurrence. In addition, MRI is a practical, noninvasive technique for follow-up of small hemangiomas., (© 2024 S. Karger AG, Basel.)
- Published
- 2024
- Full Text
- View/download PDF
27. Multifocal Infantile Hemangioma - Presentation of 4 Cases and Review of the Selected Literature.
- Author
-
Matić A, Matić M, Prćić S, Radulović A, Pajić M, and Žeravica M
- Subjects
- Humans, Male, Female, Infant, Infant, Newborn, Liver Neoplasms pathology, Liver Neoplasms therapy, Skin Neoplasms pathology, Skin Neoplasms diagnosis, Skin Neoplasms therapy, Hemangioma therapy, Hemangioma diagnosis
- Abstract
Background: Multifocal infantile hemangiomas (IHs) are focal cutaneous lesions affecting more than 1 anatomic site. The multifocal distribution pattern is the rarest form of IH manifestation, accounting for only 3-4% of all affected infants. This type of cutaneous IHs may be a marker for extracutaneous disease, with the liver being the most frequently affected organ., Methods: We investigated the clinical and epidemiological characteristics of a small case series of infants with multifocal IHs presenting with different clinical patterns, all diagnosed and treated in a regional tertiary-care pediatric clinic., Results: Four infants with multifocal IHs were included in the analysis. There were 3 girls and 1 boy. Three out of 4 infants were prematurely born (2 of them very preterm), while only 1 was full-term. Clinical patterns in all cases were quite different, but more than 20 cutaneous IHs were present in each of the patients. Two infants had multifocal liver hemangioma, but without complications. In 3 out of 4 patients, systemic propranolol therapy was introduced, with excellent response in two cases (both with liver involvement)., Conclusion: With the increase in the number of cutaneous IHs, the probability of internal organ involvement, most often the liver, also increases. Evaluation for extracutaneous lesions is indicated in infants with 5 or more cutaneous IHs. Treatment of infants with multifocal IHs should be individualized and consider all relevant risk factors, including prematurity.
- Published
- 2023
28. [Advances in the treatment of infantile hemangiomas of the larynx].
- Author
-
Gao X, Zhan X, and Gu Q
- Subjects
- Child, Preschool, Humans, Infant, Infant, Newborn, Hemangioma therapy, Hemangioma diagnosis, Hemangioma, Capillary, Laryngeal Neoplasms surgery, Larynx pathology, Soft Tissue Neoplasms
- Abstract
Infantile hemangiomas are relatively common soft tissue tumors in infants and young children, with a prevalence of about 4.5% in full-term newborns. Subglottic Hemangioma (SGH) is a relatively rare type of hemangioma, and its special location often causes respiratory distress and potentially life-threatening conditions in infants. Therefore, it is necessary for clinicians to make an accurate diagnosis and formulate a detailed treatment plan based on the clinical manifestations, the auxiliary examinations, the medical history and the vital signs evaluation of patients.This review describes the pathophysiological mechanism of infantile hemangioma and provides a detailed discussion on commonly used treatment methods in detail., Competing Interests: The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose., (Copyright© by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery.)
- Published
- 2023
- Full Text
- View/download PDF
29. A case of large airway and orbital hemangiomas with facial capillary malformation.
- Author
-
Kreher MA, Siegel LH, and Shmuylovich L
- Subjects
- Humans, Child, Female, Infant, Capillaries abnormalities, Hemangioma therapy, Vascular Malformations complications, Vascular Malformations diagnosis, Vascular Malformations genetics, Hemangioma, Capillary complications, Hemangioma, Capillary drug therapy, Musculoskeletal Abnormalities
- Abstract
Infantile hemangiomas (IHs) are the most common pediatric vascular tumors, although their genetic etiology is largely unknown. Congenital capillary malformations (CMs) are associated with known somatic pathogenic variants, including GNAQ, GNA11, PIK3CA, and PIK3R1. Co-occurrence of a facial CM such as port wine stain and IH is not associated with any recognized vascular anomaly syndromes and rarely reported in the literature. We describe a case of a 5-week-old female patient with a large facial CM and extensive IHs of the lower lip, airway, and orbit who presented with airway compromise and responded to propranolol therapy., (© 2023 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
30. A case study regarding treating the congenital hemangioma over penis and scrotum by interventional embolization.
- Author
-
Wang C, Wu F, Peng W, and Jiang H
- Subjects
- Male, Humans, Scrotum, Penis surgery, Pelvis, Hemangioma therapy, Embolization, Therapeutic
- Published
- 2023
- Full Text
- View/download PDF
31. Foam Sclerotherapy in the Treatment of Hemangiomas and Venous Malformations.
- Author
-
Yang C, Li M, Li X, Zhu J, and Shu C
- Subjects
- Humans, Sclerotherapy adverse effects, Sclerotherapy methods, Sclerosing Solutions adverse effects, Treatment Outcome, Polidocanol therapeutic use, Retrospective Studies, Vascular Malformations drug therapy, Hemangioma therapy, Hemangioma, Capillary drug therapy
- Abstract
Background: Sclerotherapy has achieved great success in treating most venous malformation (VM) lesions., Objective: To compare the effects of foam sclerotherapy on infantile hemangioma and pyogenic granuloma (PG). In addition, we analyzed the data and outcomes of foam sclerotherapy for the VM., Materials and Methods: Thirty-nine patients with hemangiomas and 83 patients with VMs were treated, and clinical outcomes, resolution, and complication rates were compared. Sclerotherapy data from the VM group were also analyzed., Results: The average age of the patients and the distribution and tissue involvement of lesions among the 3 groups were significantly different ( p < .001). The average amount of sclerosing foam administered per session in VMs was significantly higher than that in the other 2 groups ( p < .0001) (whereas that in the PG group was lower than that in the infantile hemangioma group [ p < .0001]). However, the overall therapeutic efficacy and side effects in the 3 groups were not significantly different. For VMs, the frequency of ultrasound guided foam sclerotherapy and use of 3% polidocanol increased from superficial to deep lesions, whereas the use of 1% POL decreased ( p < .0001)., Conclusion: Infantile hemangioma and PG treatments presented good results and minor adverse reactions comparable with those of VMs., (Copyright © 2023 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
32. A 16-year retrospective study of vascular anomalies in the head and neck region.
- Author
-
Leyman B, Govaerts D, Dormaar JT, Meeus J, Bila M, Coropciuc R, Willaert R, and Politis C
- Subjects
- Humans, Retrospective Studies, Head pathology, Hemangioma diagnosis, Hemangioma pathology, Hemangioma therapy, Vascular Malformations diagnostic imaging, Vascular Malformations therapy
- Abstract
Depending on the diagnostic modality, the classification of vascular anomalies varies and so does the nomenclature. The 'International Society for the Study of Vascular Anomalies' (ISSVA) is the most widely accepted classification in the literature and is mainly based on the radiologic and clinical presentation. The aim of this article is to review the clinical practice of diagnosis and treatment of vascular anomalies in the head and neck region in a university hospital, with special focus on the nomenclature. All patients with a vascular anomaly presenting to the department of oral and maxillofacial surgery were reviewed in a retrospective manner. Nomenclature, diagnostic process, lesion characteristics, treatment and outcome were examined. The lesions were (re)classified according to the ISSVA classification. A total of 185 patients were identified, of which 12.4% (n = 23) had a congenital anomaly. After reclassification, the most common lesions were venous malformations (n = 47, 25.4%), followed by lobular capillary hemangiomas (n = 17, 9.2%). A group of 39 anomalies could not be further specified. One hundred and one patients (54,6%) received treatment, of which 93 were treated surgically (92,1% of treated patients). Endovascular treatment was considered in 41 patients but applied in only eight. This strict selection led to a low a complication rate. We provide an overview of the clinical practice in the management of vascular anomalies in a university hospital. The histology report is a source of miscommunication because clinicians use the ISSVA classification, while pathologists use the WHO classification. Every professional involved should be aware of the differences in classification and nomenclature., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
33. Intramuscular capillary-type hemangioma: Diagnosis, treatment, and outcomes. A French multicentric retrospective study of 66 cases.
- Author
-
Orly J, Bisdorff A, Fraissenon A, Joly A, Boulouis G, Guibaud L, Tavernier E, Mallet S, Marcelin C, Miquel J, Martin L, Droitcourt C, Gusdorf L, Abasq C, Dadban A, Chiaverini C, Vabres P, Herbreteau D, Boccara O, Wassef M, and Maruani A
- Subjects
- Humans, Adult, Retrospective Studies, Magnetic Resonance Imaging, Neck pathology, Hemangioma diagnostic imaging, Hemangioma therapy, Arteriovenous Malformations
- Abstract
Purpose: Intramuscular capillary-type hemangiomas (ICTHs) are rare entities, belonging to the group of intramuscular "hemangiomas." The diagnosis remains challenging. We aimed to assess the diagnostic criteria, treatments and outcomes of ICTHs., Methods: This retrospective study collected all cases of ICTH followed up in 9 French hospital centers, reviewed by an adjudication expert group., Results: Among 133 patients screened, 66 with ICTH were included. The median age of patients at diagnosis was 28.0 years, interquartile range (21.0---36.0). The lesion, mainly presenting as a gradually increasing mass (83.9%), was painless (88.9%) and was located in the head and neck (42.4%). MRI (available in all cases) mainly revealed a well-delineated lesion, isointense to the muscle on T1-weighted images, with enhancement after contrast injection; hyperintense on T2-weighted images; and containing flow voids. Among the 66 cases, 59 exhibited typical ICTH features and 7 shared some imaging features with arteriovenous malformations. These latter were larger than typical ICTHs and more painful and appeared on imaging as less well delimited and more heterogeneous tissue masses, with larger tortuous afferent arteries, earlier draining vein opacification and mild arteriovenous shunting. We propose to name these lesions arteriovenous malformation (AVM)-like ICTH. Pathological reports were similar in typical and AVM-like ICTH, showing capillary proliferation with mainly small-size vessels, negative for GLUT-1 and positive for ERG, AML, CD31 and CD34, with low Ki67 proliferation index (<10%), and adipose tissue. The most frequent treatment for ICTH was complete surgical resection (17/47, 36.2%), preceded in some cases by embolization, which led to complete remission., Conclusions: ICTH can be diagnosed on MRI when it is typical. Biopsy or angiography are required for atypical forms., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2023
- Full Text
- View/download PDF
34. Congenital and Infantile Hemangiomas: Epidemiological, Clinical, and Treatment Characteristics Based on 3 Years' Experience at a Tertiary Care Hospital - A Retrospective Case Comparison and Review of the Literature.
- Author
-
Melgosa Ramos FJ, Díaz-Corpas T, Santos-Alarcón S, Galarreta Pascual M, Aguado Vázquez A, and Mateu Puchades A
- Subjects
- Humans, Infant, Retrospective Studies, Tertiary Care Centers, Biopsy, Treatment Outcome, Hemangioma, Capillary, Hemangioma diagnosis, Hemangioma epidemiology, Hemangioma therapy, Skin Neoplasms diagnosis, Skin Neoplasms epidemiology, Skin Neoplasms therapy
- Abstract
Distinguishing between congenital and infantile hemangiomas is challenging, but essential for appropriate treatment. The immunohistochemical marker glucose transporter type 1 is helpful, but biopsies are uncommon in this setting. The aim of this retrospective study was to describe and compare epidemiological, clinical, and treatment characteristics of congenital and infantile hemangiomas diagnosed at a tertiary care hospital over 3 years. We studied 107 hemangiomas: 34 congenital hemangiomas (rapidly involuting, partially involuting, and noninvoluting), 70 infantile hemangiomas, and 3 hemangiomas pending classification. Superficial infantile hemangiomas of the head and neck were the most prevalent tumors. Congenital hemangiomas were most often located on the trunk. Studied risk factors were more common in patients with infantile hemangiomas. In this group of patients, treatment response was independent of sex, in vitro fertilization, lesion depth and location, and type of treatment., (Copyright © 2023 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
35. Infantile hemangioma models: is the needle in a haystack?
- Author
-
Kong M, Li Y, Wang K, Zhang S, and Ji Y
- Subjects
- Infant, Humans, Treatment Outcome, Hemangioma therapy, Hemangioma pathology
- Abstract
Infantile hemangioma (IH) is the most prevalent benign vascular tumor in infants, with distinct disease stages and durations. Despite the fact that the majority of IHs can regress spontaneously, a small percentage can cause disfigurement or even be fatal. The mechanisms underlying the development of IH have not been fully elucidated. Establishing stable and reliable IH models provides a standardized experimental platform for elucidating its pathogenesis, thereby facilitating the development of new drugs and the identification of effective treatments. Common IH models include the cell suspension implantation model, the viral gene transfer model, the tissue block transplantation model, and the most recent three-dimensional (3D) microtumor model. This article summarizes the research progress and clinical utility of various IH models, as well as the benefits and drawbacks of each. Researchers should select distinct IH models based on their individual research objectives to achieve their anticipated experimental objectives, thereby increasing the clinical relevance of their findings., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
36. Update on the diagnosis and treatment of choroidal hemangioma.
- Author
-
García Caride S, Fernández-Vigo JI, and Valverde-Megías A
- Subjects
- Humans, Fluorescein Angiography, Choroid Neoplasms diagnosis, Choroid Neoplasms therapy, Hemangioma diagnosis, Hemangioma therapy, Hemangioma pathology, Sturge-Weber Syndrome diagnosis, Sturge-Weber Syndrome therapy, Sturge-Weber Syndrome complications
- Abstract
Choroidal hemangioma (CH) is a benign vascular tumor dependent on the choroid. Two types of lesions are distinguished: circumscribed (CCH), the most frequent variant, and diffuse (DCH), normally associated with Sturge-Weber syndrome. HCC appears as an orange mass that can present asymptomatically, however, when it produces symptoms, the most frequent is decreased visual acuity due to neurosensory retinal detachment. Due to its benign nature, only those that produce symptoms should be eligible for treatment. Knowledge of this pathology and its correct differential diagnosis is very relevant to establish the appropriate diagnosis and treatment, avoiding unnecessary treatments. There is currently a wide variety of multimodal diagnostic imaging tests that allow us to identify and adequately monitor this tumor. In addition, in recent years, there has been a change in the paradigm of the treatment of these tumors thanks to the use of photodinamic therapy, which has led to a significant improvement in the visual prognosis of these patients. This has been due to the use of photodynamic therapy as the treatment of choice for HCC., (Copyright © 2023 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
37. Infantile Hemangiomas: A Review of Current Treatment Options.
- Author
-
Dahan E and Abou Jaoude L
- Subjects
- Child, Humans, Physical Examination, Hemangioma diagnosis, Hemangioma therapy
- Abstract
This literature review outlines the current pathogenesis, clinical features, and complications of infantile hemangiomas and explores the current treatment modalities, including corticosteroids, surgery, pulsed dye laser, and beta-blockers. Although oftentimes benign, these lesions can potentially lead to physical or cosmetic disfigurement in growing children. The issue of depth and location-dependent treatment for infantile hemangiomas is explored as it reveals which treatments are correlated with better outcomes in specific presentations. For example, beta-blockers were found to be an effective first-line treatment for superficial infantile hemangiomas specifically, whereas the pulsed dye laser procedure was shown to be an effective option for deep hemangiomas, speeding up the involution process when combined with other treatment modalities and reducing scarring in ulcerated hemangiomas. Although the various infantile hemangioma treatment modalities available are appropriately tailored to specific cases of hemangiomas, they are also not without significant, sometimes life-threatening complications. This is why this literature review aims to outline the therapeutic benefits and risks of all treatment modalities to aid in the establishment of optimal case-dependent treatments. [ Pediatr Ann . 2023;52(5):192-197.] .
- Published
- 2023
- Full Text
- View/download PDF
38. Infantile Hemangioma: A Common Lesion in a Vulnerable Population.
- Author
-
Nazemian S, Sharif S, and Childers ELB
- Subjects
- Child, Humans, Infant, Vulnerable Populations, Referral and Consultation, Patients, Hemangioma, Capillary, Hemangioma diagnosis, Hemangioma pathology, Hemangioma therapy, Skin Neoplasms
- Abstract
Infantile hemangioma (IH) is important to all dentists, particularly dentists providing services to pediatric populations, because significant morbidity and mortality can occur from vascular lesions in children. Specialists of the oral cavity have the responsibility to identify patients with IH, a lesion that could be potentially life threatening. We present a case of IH and will provide a narrative review of the most recent literature. We discuss the diagnosis, risk stratification, treatment, complications, and impact on routine dental procedures. A proper diagnosis is crucial as oral and perioral IH are considered high-risk due to the increased risk of ulceration and feeding impairment. Referral to a hemangioma specialist for comprehensive team treatment is optimal. The natural history of IH consists of a long proliferative phase, which manifests as clinically visible growth. As a result of early encounters with patients, the pediatric dentist may often be considered the primary care provider.
- Published
- 2023
- Full Text
- View/download PDF
39. Bleomycin-Ethiodized Oil Transarterial Embolization of a Giant Hepatic Hemangioma.
- Author
-
Zhang L, Shi H, Zheng C, and Liang B
- Subjects
- Humans, Bleomycin, Ethiodized Oil, Hemangioma therapy, Embolization, Therapeutic, Liver Neoplasms therapy
- Published
- 2023
- Full Text
- View/download PDF
40. Chorioangioma: a single tertiary care center retrospective study.
- Author
-
Saeed B, Tulbah A, Bintalib M, De Vol EB, Almogbel S, BaAli M, Bukhari H, Foudaneel M, Almutairi J, Mahfodh MB, Tulbah M, Alnemer M, and Kurdi W
- Subjects
- Pregnancy, Humans, Female, Retrospective Studies, Tertiary Care Centers, Placenta, Ultrasonography, Prenatal, Placenta Diseases diagnosis, Placenta Diseases epidemiology, Placenta Diseases therapy, Hemangioma diagnosis, Hemangioma epidemiology, Hemangioma therapy
- Abstract
Objectives: Chorioangioma represents a challenge due to the rarity of the condition, paucity of sufficient management guidelines, and controversies regarding the best invasive fetal therapy option; most of the scientific evidence for clinical treatment has been limited to case reports. The aim of this retrospective study was to review the natural antenatal history, maternal and fetal complications, and therapeutic modalities used in pregnancies complicated with placental chorioangioma at a single Center., Methods: This retrospective study was conducted at King Faisal Specialist Hospital and Research Center (KFSH&RC) in Riyadh, Saudi Arabia. Our study population included all pregnancies with ultrasound features of chorioangioma, or histologically confirmed chorioangiomas, between January 2010 and December 2019. Data were collected from the patients' medical records, including the ultrasound reports and histopathology results. All subjects were kept anonymous; case numbers were used as identifiers. Data collected by the investigators were entered into Excel worksheets in an encrypted format. A MEDLINE database was used to retrieve 32 articles for literature review., Results: Over a 10-year period between January 2010 and December 2019, 11 cases of chorioangioma were identified. Ultrasound remains the gold standard for diagnosis and follow-up of the pregnancy. Seven of the 11 cases were detected by ultrasound, allowing proper fetal surveillance and antenatal follow-up. Of the remaining six patients, one underwent radiofrequency ablation, two underwent intrauterine transfusion for fetal anemia due to placenta chorioangioma, one had vascular embolization with an adhesive material, and two were managed conservatively until term with ultrasound surveillance., Conclusions: Ultrasound remains the gold standard modality for prenatal diagnosis and follow-up of pregnancies with suspected chorioangiomas. Tumor size and vascularity play a significant role in the development of maternal-fetal complications and the success of fetal interventions. To determine the superior modality of fetal intervention mandates more data and research; nevertheless, Fetoscopic Laser Photocoagulation and embolization with adhesive material seem to be a lead choice, with reasonable fetal survival., (© 2023 Walter de Gruyter GmbH, Berlin/Boston.)
- Published
- 2023
- Full Text
- View/download PDF
41. Two Cases of Bronchial Artery Racemose Hemangioma Successfully Treated with Bronchial Artery Embolization.
- Author
-
Hashiba N, Nakae R, Yasui D, Inoue M, Maejima R, Takiguchi T, Onda H, Kim S, and Yokobori S
- Subjects
- Male, Female, Humans, Aged, 80 and over, Middle Aged, Bronchial Arteries diagnostic imaging, Bronchial Arteries surgery, Vascular Surgical Procedures, Hemangioma complications, Hemangioma diagnostic imaging, Hemangioma therapy, Embolization, Therapeutic, Aneurysm
- Abstract
Rupture of a racemose hemangioma causing dilatation and tortuosity of the bronchial artery can result in massive bleeding and respiratory failure. Bronchial artery embolization (BAE) can treat this life-threatening condition, as we show in two cases. The first case was of an 89-year-old female complaining of sudden-onset chest and back pain. Bronchial artery angiography demonstrated a racemose hemangioma with a 2 cm aneurysm. The second case was of a 50-year-old male with hemoptysis and dyspnea, eventually requiring intubation. Bronchial arteriography showed a racemose hemangioma and a bronchial artery-pulmonary arterial fistula. BAE was successfully performed in both cases, with no recurrent hemorrhage. Therapeutic interventions in bronchial artery racemose hemangiomas include lobectomy or segmentectomy, bronchial arterial ligation, and BAE. BAE should be considered as first-line therapy for bleeding racemose hemangiomas of the bronchial artery because of its low risk of adverse effects on respiratory status, minimal invasiveness, and faster patient recovery.
- Published
- 2023
- Full Text
- View/download PDF
42. Skin sequelae in patients with infantile hemangioma: a systematic review.
- Author
-
Li W, Kang J, Bai S, Yuan L, Liu J, Bi Y, Sun J, and He Y
- Subjects
- Humans, Infant, Skin pathology, Disease Progression, Vascular Neoplasms, Skin Neoplasms complications, Skin Neoplasms therapy, Hemangioma complications, Hemangioma therapy
- Abstract
Infantile hemangioma (IH) is the most common vascular tumor in infancy. Although IHs can regress spontaneously, some problematic IHs still need treatment. However, either treated or untreated IHs may leave skin sequelae which can cause permanent disfigurement. Many studies evaluated the short-term efficacy of different kinds of treatment, but now, few studies are focusing on long-term skin sequelae. The objectives of our systemic review were to identify skin sequelae of IH thoroughly, determine specific factors associated with long-term IH sequelae, and learn how to improve these sequelae. We searched the following electronic databases: PubMed, EMBASE, Cochrane Library, and Clinicaltrials.gov. Three independent authors assessed the articles, and we reported this systemic review following PRISMA guidelines. Of 4448 articles initially identified, 62 underwent full-text review, and 17 met inclusion criteria. The overall rate of sequelae ranged from 5.3 to 93.5%. Factors associated with skin sequelae included patients' demographics, hemangioma characteristics, and treatment factors. What is Known: • Infantile hemangioma is the most common vascular tumor during infancy. • Infantile hemangiomas can regress spontaneously but either treated or untreated patients may leave permanent skin sequelae. What is New: • Skin sequelae in involuted Infantile hemangiomas are very common. • It is significant to prevent, recognize, and improve skin sequelae of infantile hemangiomas., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
43. Letter to editor regarding "Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument".
- Author
-
Frieden IJ, Mancini AJ, Blei F, Darrow DH, and Krowchuk DP
- Subjects
- Humans, Practice Guidelines as Topic, Hemangioma therapy
- Published
- 2023
- Full Text
- View/download PDF
44. Infantile Hemangiomas: A Review and Future Opportunities.
- Author
-
Eisenstein KA
- Subjects
- Infant, Humans, Endothelial Cells, Missouri epidemiology, Hemangioma diagnosis, Hemangioma therapy, Drug-Related Side Effects and Adverse Reactions, Skin Neoplasms diagnosis, Skin Neoplasms therapy
- Abstract
Infantile hemangiomas (IHs) are identified in about 5-12% of infants, making them the most common benign tumor of childhood (Figure 1). IHs are vascular growths characterized by an abnormal proliferation of endothelial cells and aberrant blood vessel architecture.1 IHs commonly involute after proliferation, traditionally leading to a non-interventional or "wait and see" management approach. However, a large subset of these growths can become problematic causing morbidities such as ulceration and scarring, disfigurement, or functional impairment. Another subset of these cutaneous hemangiomas may also be markers for visceral involvement or other underlying abnormalities. Historically, treatment options were often rife with unwanted side effects and modest results. However, with newer established treatments which are both safe and effective, there is a time-sensitive need for early identification of high-risk hemangiomas to ensure prompt delivery of treatment for best outcomes. Despite a more recent dissemination of awareness of IHs and these newer treatments, there remains a large subset of infants who still experience a delay in care and poor outcomes which are likely avoidable. There may be some avenues in Missouri to help mitigate these delays., (Copyright 2023 by the Missouri State Medical Association.)
- Published
- 2023
45. Systematic review of pediatric postcricoid cushion and postcricoid lesions.
- Author
-
Lee A and Patel NA
- Subjects
- Child, Cricoid Cartilage pathology, Female, Humans, Infant, Infant, Newborn, Male, Prolapse, Deglutition Disorders etiology, Hemangioma diagnosis, Hemangioma therapy, Laser Therapy adverse effects
- Abstract
Objectives: It is thought that many infants have a prominent venous plexus of the postcricoid area. In the past this entity had occasionally been reported as a postcricoid hemangioma or even a postcricoid mass. The term postcricoid cushion is now gaining acceptance to describe the prominent venous plexus of the posterior cricoid area. Although it rarely causes symptoms, it should be considered when patients present with symptoms of obstruction. Differentiating between normal variant postcricoid prominent venous plexuses, hemangiomas, and vascular malformations can be difficult and cannot be confirmed without immunohistochemistry. The objective of this systematic review is to describe current practices, clinical symptoms, management and outcomes of pediatric postcricoid lesions including postcricoid cushion., Methods: A systemic review of the literature was done using the PRISMA (Preferred Reporting Items for Systemic Reviews and Meta-Analyses) guidelines to investigate postcricoid lesions. The following terms: Postcricoid, Postcricoid lesions, Postcricoid mass, Posterior cricoid, Pressure-dependent postcricoid mass, postcricoid prolapse, postcricoid hemangiomas, postcricoid vascular malformations, and postcricoid cushion were searched in PubMed and Google Scholar. Articles that were within the inclusion criteria were reviewed. Demographics, past medical and birth histories, clinical symptoms, evaluations, biopsy results, treatments, and outcomes were included. For the purposes of this review, postcricoid cushions, pressure-dependent postcricoid mass, and postcricoid prolapse will be group under normal variant postcricoid cushion., Results: 15 articles with 42 distinct cases were included in this systemic review. 21/42 of the patients were female, the age ranged from 2 days to 18 years, the median age was 6.5 months, and 39/42 of patients were under the age of 2 years. 17/42 patients were diagnosed "hemangiomas" in the papers with only 1 case confirming the diagnosis of hemangioma with immunohistochemistry. 7/42 were diagnosed vascular malformations with 3 cases confirming the diagnosis of with immunohistochemistry. 17/42 of cases were normal variant postcricoid cushions. Most commonly, patients had a history of laryngomalacia (14/33) followed by no other medical history (9/33). The most common clinical symptoms were stridor, dysphonia, or weak cry in 30/42, dysphagia in 20/42, sleep disordered breathing in 9/42, and regurgitation or aspiration in 9/42.8/38 of patients diagnosed with postcricoid cushion did not have visualization of the lesion until a Valsalva maneuver was performed. The most common management for "hemangiomas" was observation (8/17), for "vascular malformations" was laser therapy (3/7), and for normal variant postcricoid cushions was observation (8/17). The most common outcome was complete resolution (14/30) followed by improvement of symptoms (9/30), and residual complications (4/30) The median time to follow-up was 12 months., Conclusion: Due to the relatively new "discovery" of the normal variant postcricoid cushion, including postcricoid cushion, pressure-dependent postcricoid mass, and postcricoid prolapse, the majority of the literature are case reports. Although it is theorized that many children under the age of 2 have a prominent venous plexus, in some cases it could cause symptoms of obstruction. Because immunohistochemistry is rarely done and reported in the literature, many case reports may have misdiagnosed the postcricoid lesions. Also, in many cases visualizing the normal variant postcricoid cushion requires that the patients have increased intrathoracic pressure; therefore, if no postcricoid prominence is seen initially or when the patient is under general anesthesia and a postcricoid lesion is suspected, the patient should receive a Valsalva maneuver or be placed in Trendelenburg position. Most cases of normal variant postcricoid cushions can be managed with observation. Due to the rarity and novelty of the discovery, more research needs to be done on the management of symptomatic postcricoid lesions and differentiating between normal variants and pathological vascular lesions., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
46. Computed Tomography Fluoroscopy-Guided Percutaneous Transhepatic Bleomycin/Ethiodized Oil Sclerotherapy for Symptomatic Giant Hepatic Hemangioma.
- Author
-
Ghanaati H, Abrishami A, Hashem Zadeh A, Ghiasi M, Nasiri Toosi M, and Jafarian A
- Subjects
- Humans, Ethiodized Oil, Bleomycin adverse effects, Treatment Outcome, Sclerotherapy adverse effects, Sclerotherapy methods, Tomography, X-Ray Computed, Hemangioma diagnostic imaging, Hemangioma therapy, Hemangioma pathology, Liver Neoplasms diagnostic imaging, Liver Neoplasms therapy, Liver Neoplasms pathology
- Abstract
Purpose: To determine the safety and efficacy of computed tomography (CT) fluoroscopy-guided percutaneous transhepatic sclerotherapy with a bleomycin/ethiodized oil emulsion for symptomatic giant hepatic hemangiomas., Materials and Methods: The procedure was performed on 22 patients with symptomatic giant hepatic hemangiomas in an outpatient setting between 2018 and 2020. All patients were followed clinically and underwent contrast-enhanced magnetic resonance imaging after 1 month and again at a mean time of 15 months ± 2. Adverse events were classified according to the Common Terminology Criteria for Adverse Events (CTCAE, v5.0), in which a severe adverse event was defined as an adverse event with a grade of ≥3. The desired radiologic response (volume and index size) and improvement of pain intensity (visual analog scale [VAS]) and other symptoms were recorded as outcomes., Results: Overall, patients showed a 36.4% ± 8.6 reduction in volume and a 14% ± 1.6 reduction in index size after 1 month, with P values of .002 and .001, respectively. The final follow-up volume and index size were 194.7 cm
3 ± 25.8 and 77 mm ± 36, respectively. Moreover, a 53.0% ± 7 reduction in volume and 22% ± 3.7 reduction in index size during the final imaging were reported, with the P values of .001 and .001, respectively. Significant reductions in the mean pain intensity (90% of patients with lower VAS scores after intervention) and symptoms were reported. Four patients were classified as clinically unsuccessful, and were recommended further procedures for residual pain., Conclusions: CT fluoroscopy-guided transhepatic sclerotherapy is an effective, safe, and minimally invasive method to manage giant hepatic hemangiomas in an outpatient setting., (Copyright © 2022 SIR. Published by Elsevier Inc. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
47. Intrauterine transfusion of a hydropic fetus with anemia due to a giant chorioangioma: A case report.
- Author
-
de la Luz Bermudez-Rojas M, Medina-Jimenez V, Lira-Diaz A, Sanchez-Rodriguez MA, Valdespino-Vazquez MY, and Martinez-Portilla RJ
- Subjects
- Pregnancy, Infant, Newborn, Female, Humans, Blood Transfusion, Intrauterine, Hydrops Fetalis diagnostic imaging, Hydrops Fetalis etiology, Hydrops Fetalis therapy, Fetus, Placenta Diseases, Hemangioma complications, Hemangioma therapy, Anemia complications, Anemia therapy
- Abstract
Giant chorioangiomas are a potentially life-threatening condition that may require intrauterine therapy. We describe a case of a large chorioangioma (>4cm) diagnosed at 30 weeks of gestation causing severe fetal anemia and hydrops. An intrauterine blood transfusion was performed at 31 weeks with reversal of the anemia and hydrops. The neonate was born at 37 weeks showing respiratory distress syndrome that required neonatal intensive care unit admission but was discharged at 30 days of life. Further evaluation at two months of age showed no signs of abnormal neurodevelopment. When timely indicated, intrauterine transfusion of a hydropic fetus with anemia due to a giant chorioangioma is a potentially life-saving therapy that shows good neurodevelopment of the surviving fetus., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022. Published by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF
48. Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument.
- Author
-
De Ravin E, Barrette LX, Lu J, Xu K, Suresh N, Romeo D, Moreira A, and Rajasekaran K
- Subjects
- Humans, Infant, Reproducibility of Results, Hemangioma diagnosis, Hemangioma therapy, Practice Guidelines as Topic
- Abstract
Infantile hemangiomas (IH) are the most common benign tumors of childhood. Timely diagnosis and management of higher-risk IH is key in avoiding permanent disfigurement, visual impairment, and life-threatening airway compromise. Here, we identify and critically appraise existing clinical practice guidelines (CPGs) for IH diagnosis and management. A systematic search of MEDLINE, SCOPUS, and EMBASE was conducted until August 2021. Four independent reviewers assessed each CPG utilizing the Appraisal of Guidelines for Research and Evaluation, 2
nd edition (AGREE II). An scaled domain score of ≥60% demonstrated adequacy in a given domain. Intraclass correlation coefficients (ICC) assessed agreement and scoring consistency between the reviewers. Eight CPGs were eligible and included for critical appraisal. Only one CPG was classified as 'high quality', with the remaining seven guidelines being 'average' ( n = 3) or 'low' ( n = 4) quality. Six guidelines (75.0%) were conducted via nonsystematic literature searches. The 'Applicability' (40.4%±14.0) and 'Rigor of development' (46.9%±17.3) domains achieved the lowest scores, while the highest average scores were in 'Scope and purpose' (76.7%±11.3) and 'Editorial independence' (90.8%±13.0). We found high consistency between the four independent reviewers, with 'very good' ( n = 5) or 'good' ( n = 1) interrater reliability in all six AGREE II domains. Based on the AGREE II instrument, there is only one available high-quality consensus statement on the diagnosis and management of IH. Low scores in 'Rigor of development' and 'Applicability' suggest notable weaknesses in the development process and reporting quality of existing IH CPGs. Future guidelines should be backed by systematic literature searches and focus on guideline clinical translation.- Published
- 2022
- Full Text
- View/download PDF
49. Intracranial Virotherapy for a Canine Hemangioma.
- Author
-
Delgado-Bonet P, Tomeo-Martín BD, Delgado-Bonet B, Sardón-Ruiz D, Torrado-Carvajal A, Mateo I, and Perisé-Barrios AJ
- Subjects
- Adenoviridae genetics, Animals, Dogs, Tumor Microenvironment, Hemangioma therapy, Hemangioma veterinary, Neoplasms therapy, Oncolytic Virotherapy methods, Oncolytic Viruses genetics
- Abstract
Intracranial hemangiomas are rare neoplastic lesions in dogs that usually appear with life-threatening symptoms. The treatment of choice is tumor resection; however, complete resection is rarely achieved. The patient's prognosis therefore usually worsens due to tumor progression, and adjuvant treatments are required to control the disease. Oncolytic viruses are an innovative approach that lyses the tumor cells and induces immune responses. Here, we report the intratumoral inoculation of ICOCAV15 (an oncolytic adenovirus) in a canine intracranial hemangioma, as adjuvant treatment for incomplete tumor resection. The canine patient showed no side effects, and the tumor volume decreased over the 12 months after the treatment, as measured by magnetic resonance imaging using volumetric criteria. When progressive disease was detected at month 18, a new dose of ICOCAV15 was administered. The patient died 31.9 months after the first inoculation of the oncolytic adenovirus. Furthermore, tumor-infiltrated immune cells increased in number after the viral administrations, suggesting tumor microenvironment activation. The increased number of infiltrated immune cells, the long survival time and the absence of side effects suggest that ICOCAV15 could be a safe and effective treatment and should be further explored as a novel therapy for canine hemangiomas.
- Published
- 2022
- Full Text
- View/download PDF
50. Timing and Rationale of Treatment: Achieving the "Best Result".
- Author
-
Hochman M
- Subjects
- Humans, Infant, Hemangioma therapy, Hemangioma, Capillary
- Abstract
Various clinical disciplines defend the modality of therapy available to them (eg, medical vs surgery) when, in fact, multi-modality therapy is usually in the best interest of the patient. The aim of any modality of treatment is to obtain the best possible result for a given patient. To successfully achieve that aim for infantile hemangiomas (IH) and all vascular anomalies, defining what is meant by the best possible result and by when to achieve that, the result needs to be defined. Perhaps more important is to make a determination of what is an acceptable result. The impact of a 1-cm IH of the nasal tip is different from that of the same exact lesion on the thigh. The functional import of a 5-mm IH involving the lower eyelid is potentially very different from the same lesion involving the upper eyelid. These examples highlight that variables, such as size and location, are important. What is considered acceptable as a result of treatment of the nasal tip and upper eyelid IH is different from that for the corresponding thigh and lower lid lesions., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.